Agios to Webcast Conference Call of Second Quarter 2021 Financial Results on July 29, 2021
July 15 2021 - 7:00AM
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field
of cellular metabolism to treat genetically defined diseases, today
announced that the company will host a conference call and live
webcast on Thursday, July 29, 2021 at 8:00 a.m.
ET to report its second quarter 2021 financial results and
other business highlights.
A live webcast can be accessed under "Events &
Presentations" in the Investors section of the company's website
at www.agios.com. The conference call can be accessed by
dialing 1-877-377-7098 (domestic) or 1-631-291-4547 (international)
and referring to conference ID 2663508. The webcast will be
archived and made available for replay on the company's website
beginning approximately two hours after the event.
About AgiosAgios is focused on discovering and
developing novel investigational medicines to treat genetically
defined diseases through scientific leadership in the field of
cellular metabolism. The company’s most advanced drug candidate is
a first-in-class pyruvate kinase R (PKR) activator, mitapivat, that
is currently being evaluated for the treatment of three distinct
hemolytic anemias. In addition to its active late-stage clinical
pipeline, Agios has multiple novel, investigational therapies in
clinical and preclinical development. For more information, please
visit the company’s website at www.agios.com.
Contacts
Investors: 1AB Steve
Klasssteve@1abmedia.com
Media: 1AB Josie Butlerjosie@1abmedia.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Sep 2023 to Sep 2024